AAAAAA

   
Results: 1-4 |
Results: 4
USE OF BISPHOSPHONATES IN PATIENTS WITH METASTATIC BONE-DISEASE - THEBERENSON LIPTON ARTICLE REVIEWED/
Authors: BERGSAGEL DE
Citation: De. Bergsagel, USE OF BISPHOSPHONATES IN PATIENTS WITH METASTATIC BONE-DISEASE - THEBERENSON LIPTON ARTICLE REVIEWED/, Oncology, 12(11), 1998, pp. 1579-1580
THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF MULTIPLE-MYELOMA
Authors: BERGSAGEL DE
Citation: De. Bergsagel, THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF MULTIPLE-MYELOMA, Bailliere's clinical haematology, 8(4), 1995, pp. 783-794
DO GLUCOCORTICOIDS INFLUENCE THE SURVIVAL OF MYELOMA PATIENTS
Authors: BERGSAGEL DE
Citation: De. Bergsagel, DO GLUCOCORTICOIDS INFLUENCE THE SURVIVAL OF MYELOMA PATIENTS, Journal of clinical oncology, 13(4), 1995, pp. 1045-1046
DETERMINATION OF IL6, IL1, AND IL4 IN THE PLASMA OF PATIENTS WITH MULTIPLE-MYELOMA
Authors: KISS TL LIPTON JH BERGSAGEL DE MEHARCHAND JM JAMAL N MINDEN MD MESSNER HA
Citation: Tl. Kiss et al., DETERMINATION OF IL6, IL1, AND IL4 IN THE PLASMA OF PATIENTS WITH MULTIPLE-MYELOMA, Leukemia & lymphoma, 14(3-4), 1994, pp. 335-340
Risultati: 1-4 |